These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21029061)

  • 1. The aging mind: vascular health in normal cognitive aging.
    Warsch JR; Wright CB
    J Am Geriatr Soc; 2010 Oct; 58 Suppl 2():S319-24. PubMed ID: 21029061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment.
    Lindeboom J; Weinstein H
    Eur J Pharmacol; 2004 Apr; 490(1-3):83-6. PubMed ID: 15094075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plurality of patterns of cognitive impairment in normal aging and in dementia].
    Joanette Y; Belleville S; Gely-Nargeot M; Ska B; Valdois S
    Rev Neurol (Paris); 2000 Sep; 156(8-9):759-66. PubMed ID: 10992120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vascular factors in dementia].
    Bidzan L
    Psychiatr Pol; 2005; 39(5):977-86. PubMed ID: 16358596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging.
    Messier C
    Neurobiol Aging; 2005 Dec; 26 Suppl 1():26-30. PubMed ID: 16236384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IANA task force on nutrition and cognitive decline with aging.
    Gillette Guyonnet S; Abellan Van Kan G; Andrieu S; Barberger Gateau P; Berr C; Bonnefoy M; Dartigues JF; de Groot L; Ferry M; Galan P; Hercberg S; Jeandel C; Morris MC; Nourhashemi F; Payette H; Poulain JP; Portet F; Roussel AM; Ritz P; Rolland Y; Vellas B
    J Nutr Health Aging; 2007; 11(2):132-52. PubMed ID: 17435956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From neuronal and vascular impairment to dementia.
    De Deyn PP; Goeman J; Engelborghs S; Hauben U; D'Hooge R; Baro F; Pickut BA
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():17-24. PubMed ID: 10338104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension and cognitive function in the elderly.
    Cherubini A; Lowenthal DT; Paran E; Mecocci P; Williams LS; Senin U
    Dis Mon; 2010 Mar; 56(3):106-47. PubMed ID: 20189499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and cognitive function in the elderly.
    Cherubini A; Lowenthal DT; Paran E; Mecocci P; Williams LS; Senin U
    Am J Ther; 2007; 14(6):533-54. PubMed ID: 18090879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conceptualization of mild cognitive impairment: a review.
    Davis HS; Rockwood K
    Int J Geriatr Psychiatry; 2004 Apr; 19(4):313-9. PubMed ID: 15065223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of impaired physical health and age in normal cognitive aging.
    Bergman I; Blomberg M; Almkvist O
    Scand J Psychol; 2007 Apr; 48(2):115-25. PubMed ID: 17430364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cognitive changes in normal aging: nosology and current status].
    Bartrés-Faz D; Clemente I; Junqué C
    Rev Neurol; 1999 Jul 1-15; 29(1):64-70. PubMed ID: 10528315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms.
    Panza F; Frisardi V; Capurso C; Imbimbo BP; Vendemiale G; Santamato A; D'Onofrio G; Seripa D; Sancarlo D; Pilotto A; Solfrizzi V
    J Alzheimers Dis; 2010; 21(3):691-724. PubMed ID: 20571214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal cognitive changes in aging.
    Anstey KJ; Low LF
    Aust Fam Physician; 2004 Oct; 33(10):783-7. PubMed ID: 15532151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of vascular risk factors and diseases on cognition in persons with mild cognitive impairment.
    Villeneuve S; Belleville S; Massoud F; Bocti C; Gauthier S
    Dement Geriatr Cogn Disord; 2009; 27(4):375-81. PubMed ID: 19321941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for prevention and treatment of vascular cognitive impairment.
    Di Legge S; Hachinski V
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1082-7. PubMed ID: 14582452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular risk factor detection and control may prevent Alzheimer's disease.
    de la Torre JC
    Ageing Res Rev; 2010 Jul; 9(3):218-25. PubMed ID: 20385255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related cognitive decline in patients with mood disorders.
    Gualtieri CT; Johnson LG
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):962-7. PubMed ID: 18243461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cerebral white matter lesions in the elderly: vascular risk factors and cognitive consequences].
    de Leeuw FE; de Groot JC; van Gijn J
    Ned Tijdschr Geneeskd; 2001 Oct; 145(43):2067-71. PubMed ID: 11715591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.